1. Symmetrically substituted dichlorophenes inhibit -acyl-phosphatidylethanolamine phospholipase D. Aggarwal G, Zarrow JE, Mashhadi Z, Flynn CR, Vinson P, Weaver CD, Davies SS (2020) J Biol Chem 295(21): 7289-7300
    › Primary publication · 32284327 (PubMed) · PMC7247316 (PubMed Central)
  2. Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes. Flynn CR, Albaugh VL, Tamboli RA, Gregory JM, Bosompem A, Sidani RM, Winnick JJ (2020) Am J Physiol Gastrointest Liver Physiol 318(2): G370-G374
    › Primary publication · 31709832 (PubMed) · PMC7052573 (PubMed Central)
  3. Pro-inflammatory HDL in women with obesity and nonalcoholic steatohepatitis. Sarkar S, Tsuchida Y, Diab R, Xu C, Yermalitsky V, Davies SS, Ikizler TA, Hung AM, Kon V, Flynn CR (2020) Obes Res Clin Pract 14(4): 333-338
    › Primary publication · 32595023 (PubMed) · PMC7507596 (PubMed Central)
  4. Fecal metagenomics and metabolomics reveal gut microbial changes after bariatric surgery. Yu D, Shu XO, Howard EF, Long J, English WJ, Flynn CR (2020) Surg Obes Relat Dis 16(11): 1772-1782
    › Primary publication · 32747219 (PubMed)
  5. Collision Cross Section Conformational Analyses of Bile Acids via Ion Mobility-Mass Spectrometry. Poland JC, Leaptrot KL, Sherrod SD, Flynn CR, McLean JA (2020) J Am Soc Mass Spectrom
    › Primary publication · 32525305 (PubMed) · PMC8059067 (PubMed Central)
  6. Utilizing Untargeted Ion Mobility-Mass Spectrometry To Profile Changes in the Gut Metabolome Following Biliary Diversion Surgery. Poland JC, Schrimpe-Rutledge AC, Sherrod SD, Flynn CR, McLean JA (2019) Anal Chem 91(22): 14417-14423
    › Primary publication · 31573190 (PubMed) · PMC7076733 (PubMed Central)
  7. Two-week administration of engineered Escherichia coli establishes persistent resistance to diet-induced obesity even without antibiotic pre-treatment. Dosoky NS, Chen Z, Guo Y, McMillan C, Flynn CR, Davies SS (2019) Appl Microbiol Biotechnol 103(16): 6711-6723
    › Primary publication · 31203417 (PubMed) · PMC7066869 (PubMed Central)
  8. Treating Nonalcoholic Fatty Liver Disease From the Outside In? Flynn CR (2019) Cell Mol Gastroenterol Hepatol 7(3): 682-683
    › Primary publication · 30677403 (PubMed) · PMC6477184 (PubMed Central)
  9. Systemic bile acids induce insulin resistance in a TGR5-independent manner. Syring KE, Cyphert TJ, Beck TC, Flynn CR, Mignemi NA, McGuinness OP (2019) Am J Physiol Endocrinol Metab 316(5): E782-E793
    › Primary publication · 30779633 (PubMed) · PMC6732652 (PubMed Central)
  10. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery. Albaugh VL, Banan B, Antoun J, Xiong Y, Guo Y, Ping J, Alikhan M, Clements BA, Abumrad NN, Flynn CR (2019) Gastroenterology 156(4): 1041-1051.e4
    › Primary publication · 30445014 (PubMed) · PMC6409186 (PubMed Central)